Case Study: AROA Biosurgery achieves faster diabetic foot ulcer healing with Net Health data solutions

Net Health’s Data Helps AROA Biosurgery Show Superiority of Its Novel Wound Care Product

AROA Biosurgery, a New Zealand-based company, needed to prove that its Endoform™ Natural wound care product was superior to standard collagen dressings for treating diabetic foot ulcers. Their challenge was that a traditional clinical trial would be too costly, time-consuming, and not reflective of real-world patient populations. They turned to Net Health for a data-driven solution to access a large repository of real-world evidence.

Net Health provided AROA with access to its pre-existing, standardized database of wound care outcomes, along with expert consultative services from its data science team. This real-world data study analyzed over 2,200 wounds and demonstrated that Endoform™ Natural achieved wound closure 1.9 to 5.6 weeks faster than the standard dressing, an 11-21% reduction in healing time. The study's compelling results were published in the International Wound Journal, validating the product's superiority and showcasing the power of Net Health's data.

AROA Biosurgery

Barnaby May

Chief Scientific Officer